CDK4 and lung carcinoma: Likewise, tetracenomycinsare, an antibiotic produced by the Streptomyces and Nocardia species, induced cell cycle arrest in the lung cancer cells by decreasing the expression levels of cyclin D1 and CDK4 (cyclin-dependent kinase 4) [64].